Navigation Links
Embolization a Nonsurgical Way to Treat Fibroids
Date:3/18/2008

It works even after other therapies have failed, but many women unaware of this option, experts say,,

TUESDAY, March 18 (HealthDay News) -- Uterine artery embolization is an effective, non-surgical therapy for fibroids, even after a woman has had other treatments such as focused ultrasound surgery, a new study says.

But another team of researchers reports that many American women are unaware of embolization as a treatment option.

The two studies were to be presented Tuesday at the Society of Interventional Radiology's annual meeting, in Washington, D.C.

"If you're suffering with symptomatic fibroids, you don't have to have surgery. Uterine artery embolization is an excellent option," said the author of one of the studies, Dr. John Lipman, director of interventional radiology at Emory-Adventist Hospital in Atlanta. "There are some women who are silent sufferers. They basically hemorrhage each month because they know they don't want a hysterectomy and they feel it's the only option. So, they just sit on the sidelines because they don't want the surgery."

Uterine artery embolization (UAE), which is sometimes called uterine fibroid embolization, cuts off the blood supply to fibroids by blocking the uterine arteries. The procedure is minimally invasive, doesn't require general anesthesia, and often allows women to return to normal daily activities within a week, instead of the six weeks or so needed for recovery from a hysterectomy.

The downside to this procedure is that it's not effective for everyone, and in rare cases, the fibroids may recur, according to the Society of Interventional Radiology (SIR).

Other treatment options -- such as hysterectomy (surgical removal of the uterus) and myomectomy (surgical removal of individual fibroids) -- are available, as is magnetic resonance-guided focused ultrasound. This technique is also known as focused ultrasound surgery (FUS) or ablation, and involves using high-intensity ultrasound waves to destroy (ablate) fibroid tissue, according to SIR.

If ablation fails to relieve fibroid symptoms, uterine artery embolization is still an effective treatment option, according to one of the studies presented. The study evaluated the efficacy of uterine artery embolization after failed ablation, and found that the technique could still provide a reduction in fibroid size and in symptoms.

"FUS is a newer procedure for uterine fibroids and whether it provides sustained symptom relief is still being evaluated. My research shows that when FUS fails, these women could benefit from uterine fibroid embolization," the study's lead author, Dr. Alisa Suzuki, an interventional radiologist at Brigham and Women's Hospital, said in a prepared statement.

But Lipman suspected that -- despite the procedure's efficacy -- many women aren't being made aware of UAE. In his study, the Emory researcher interviewed 105 women being seen at an Atlanta-area fibroid practice to assess whether or not they had been told by their gynecologists that uterine artery embolization was an option. Lipman pointed out that gynecologists don't perform UAE, interventional radiologists do. So, if women were not informed about the procedure by their gynecologist, Lipman asked how they learned about UAE.

He found that only 33 percent of the women were given uterine artery embolization as an option, and most of these patients were referred from a single health-care organization -- one that requires doctors to present all options. The most common way that the remaining women found out about uterine artery embolization was either from radio advertisements or the Internet.

"While I encourage patients to use the Internet -- it's important for patients to empower themselves -- it's up to doctors to give their patients all the options. Gynecologists need to take the lead and tell their patients about this option. Patients shouldn't have to direct their own therapy," Lipman said.

Dr. William Romano, an interventional radiologist at William Beaumont Hospital in Royal Oak, Mich., added: "Embolization is a good treatment option and it should at least be considered in all patients with fibroids. It would be nice if the knowledge of it was more widespread."

More information

The Society of Interventional Radiology has more information on uterine artery embolization and other fibroid treatment options.



SOURCES: John Lipman, M.D., medical director, Atlanta Interventional Institute, and director, interventional radiology, Emory-Adventist Hospital, Atlanta; William Romano, M.D., interventional radiologist, William Beaumont Hospital, Royal Oak, Mich.; March 18, 2008, presentations, Society of Interventional Radiology annual meeting, Washington D.C.


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Terumo Launches the New AZUR(TM) Peripheral HydroCoil(R) Embolization System with Expanding Hydrogel Technology
2. Satisfaction After Fibroid Embolization Similar to Hysterectomy
3. Psychological intervention reduces postembolization pain
4. Few Women Hear About Uterine Fibroid Embolization Treatment Option Directly From Gynecologists
5. Study finds spine surgery yields greater benefits over nonsurgical treatments
6. Using coxibs and NSAIDs to treat osteoarthritis
7. New treatment effective in counteracting cocaine-induced symptoms
8. New treatment boosts muscle function in myasthenia gravis
9. HPV vaccine does not appear to be effective for treating pre-existing HPV infection
10. Free distribution of insecticide-treated mosquito nets can save lives
11. Kenyan malaria success strengthens call for free insecticide-treated nets for all
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Embolization a Nonsurgical Way to Treat Fibroids
(Date:6/26/2017)... ... ... KICKICO , a protocol built on Ethereum for more transparent ICO ... within funding campaigns. KICKICO developers are testing the platform, which will launch for the ... funds through the power of many - has been around for about ten years ...
(Date:6/25/2017)... ... , ... FCPX LUT Vintage Volume 2 for Final Cut Pro X allows ... 2 contains 60 different color-grade presets, giving editors multiple options for adding different color ... out subjects, plus much more. FCPX LUT Vintage Volume 2 is designed for any ...
(Date:6/25/2017)... ... 25, 2017 , ... Republicans in the United States Senate on Thursday released ... Care Reconciliation Act. It differs significantly from the American Health Care Act, which the ... committee, or the House will have to take up the Senate version as-is, if ...
(Date:6/25/2017)... ... , ... CareSet Labs released the Root NPI Graph today at the 2017 ... improved version of the Doctor Referral teaming dataset commonly available from Medicare. , Originally ... the the “Doctor Referral Dataset” as released by Medicare and “DocGraph” as released by ...
(Date:6/25/2017)... ... ... Men’s Health Month and the focus is on prostate cancer. Second only to skin ... third most common cause of cancer related death today; lung cancer remains in the number ... prostate cancer during his lifetime. Those at highest risk are men who have ...
Breaking Medicine News(10 mins):
(Date:6/19/2017)... Pa. , June 19, 2017  Researchers from ... today that they will host a live, complimentary webinar ... from the benchtop to the real world" on Wednesday ... EDT. This webinar will feature interviews ... rare look into the manipulation techniques abusers use to ...
(Date:6/14/2017)... 2017  In 2016, Embodied Labs took ... competition and came away with $25,000 in seed-fund investment. ... Forbes as "entering the life of another" and by ... "empathy to medical professionals in an entirely new dimension." ... a finalist for the Department of Education,s EdSimChallenge, where ...
(Date:6/9/2017)... , June 9, 2017 AirXpanders, Inc. (ASX: ... on the design, manufacture, sale and distribution of the ... the progress of its commercial roll-out in ... in more than one hundred (100) medical institutions and ... AeroForm offers a needle-free alternative for women who choose ...
Breaking Medicine Technology: